Berndt A. E. Modig

Berndt A. E.
Modig is the founder of Pharvaris NV, founded in 2015, where the title held is Chief Executive Officer & Executive Director.
Mr. Modig is the founder of Pharvaris GmbH, founded in 2015, where the title held is Chief Executive Officer & Director.
Current jobs include Managing Director at Schoodic Management BV, Director at Roivant Sciences, Inc., and Member-Supervisory Board at Centogene AG since 2018.
Former jobs include Vice Chairman-Supervisory Board at Kiadis Pharma NV from 2016 to 2021; Finance Director-Europe at Hayward Industrial Products, Inc. from 1999 to 2001; Director at Auris Medical AG; Director at Mobile Loyalty Plc from 2012 to 2013; Director at OncoBiotek SA; Independent Non-Executive Director at Auris Medical Holding AG from 2015 to 2018; Independent Director at Sio Gene Therapies, Inc. from 2015 to 2023; Director at Altamira Therapeutics Ltd. from 2014 to 2018; Member-Supervisory Board at Affimed NV from 2014 to 2020; Senior Manager-Financial Services at Pricewaterhouse LLP from 1991 to 1994; Chief Financial Officer at Surplex AG from 2001 to 2003; Chief Financial Officer at Shire Orphan Therapies GmbH from 2003 to 2008; Chief Financial Officer at Prosensa Holding NV from 2010 to 2015; Partner at Agra Industria from 1994 to 1999; Independent Member-Supervisory Board at Centogene NV from 2018 to 2023; Member-Supervisory Board at Affimed GmbH.
Education includes an MBA degree from INSEAD and undergraduate studies at the University of Lund.